LAB vs MAR · rev $174.4M vs P/E 32, rev $26.19B
Standard Biotools Inc (LAB) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
LAB currently screens at market cap $317.1M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the LAB and MAR stock pages for the full models.
Not investment advice.